Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Artelo Biosciences ( (ARTL) ) has shared an announcement.
On February 2, 2026, Artelo Biosciences said it received a decision from a Nasdaq Hearing Panel granting the company an exception to cure its listing deficiencies, provided it demonstrates by March 30, 2026 that it complies with the Nasdaq requirement to maintain at least $2.5 million in stockholders’ equity and discloses the transactions used to achieve and sustain that level. The exception follows a November 19, 2025 delisting determination for failure to meet the equity rule and a January 14, 2026 notice of non-compliance for not holding its 2025 annual meeting within the required timeframe; Artelo presented a remediation plan at a January 15, 2026 hearing, completed its adjourned annual meeting on January 30, 2026, and now faces a firm March 30, 2026 deadline to restore equity compliance to avoid potential delisting, creating continued uncertainty for shareholders and other stakeholders.
The most recent analyst rating on (ARTL) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Artelo Biosciences stock, see the ARTL Stock Forecast page.
Spark’s Take on ARTL Stock
According to Spark, TipRanks’ AI Analyst, ARTL is a Neutral.
The score is primarily held down by very weak financial performance (no revenue, widening losses, ongoing cash burn) and heightened balance-sheet/listing risk (negative equity and Nasdaq compliance/delisting concerns). Technicals are only neutral-to-mixed and valuation offers limited support due to negative earnings and no dividend yield data.
To see Spark’s full report on ARTL stock, click here.
More about Artelo Biosciences
Artelo Biosciences, Inc. is a Nasdaq-listed biotechnology company focused on developing pharmaceutical products, with its shares subject to Nasdaq’s continued listing standards, including minimum stockholders’ equity and corporate governance requirements such as holding timely annual shareholder meetings.
Average Trading Volume: 538,632
Technical Sentiment Signal: Sell
Current Market Cap: $2.93M
Learn more about ARTL stock on TipRanks’ Stock Analysis page.